scholarly journals Can the positions of the spastic upper limb in stroke survivors help muscle choice for botulinum toxin injections?

2019 ◽  
Vol 77 (8) ◽  
pp. 568-573 ◽  
Author(s):  
André Luiz Salcedo Gomes ◽  
Francisco Falleiros de Mello ◽  
Jorge Cocicov Neto ◽  
Marcelo Causin Benedeti ◽  
Luis Felipe Miras Modolo ◽  
...  

ABSTRACT Motor impairments in stroke survivors are prevalent and contribute to dependence in daily activities, pain and overall disability, which can further upper-limb disability. Treatment with botulinum toxin A (BoNT-A) is indicated for focal spasticity and requires knowledge of biomechanics and anatomy to best select muscles to be injected in the limb. Objective: We aimed to describe the frequency of posture patterns in a Brazilian sample of stroke survivors and correlate them with recommendations of muscle selection for treatment with BoNT-A. Methods: Fifty stroke patients with spastic upper limbs scheduled for neuromuscular block were photographed and physically examined, to be classified by three independent evaluators according to Hefter's classification. Muscles that were injected with BoNT-A by their routine doctors were retrieved from medical charts. Results: Pattern III and IV were the most common (64.7%, 21.6%). We further subclassified pattern III according to the rotation of the shoulder, which effectively interfered in muscle choice. The muscles most frequently treated were shoulder adductors and internal rotators, elbow flexors and extensors, in forearm, the pronator teres and finger and wrist flexors, and, in the hand the adductor pollicis. Conclusion: Frequencies of upper-limb postures differed from previous reports. Other clinical features, besides spasticity, interfered with muscle choice for BoNT-A injection, which only partially followed the recommendations in the literature.

2020 ◽  
Vol 33 (11) ◽  
pp. 761
Author(s):  
Alexandre Camões- Barbosa ◽  
Inês Mendes Ribeiro ◽  
Luisa Medeiros

Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin. Contralateral weakness after botulinum toxin A treatment is a rarely reported adverse effect. We report the case of a 33-year-old female who had been receiving regular injections of incobotulinum toxin A due to spasticity of the right limbs after a hemorrhagic stroke. A switch was made to abobotulinum toxin A with an overall conversion ratio of 1:3.83. The patient presented contralateral upper limb paresis, especially of the deltoid muscle, in the second week post-injection. The electroneuromyography showed neuromuscular block due to botulinum toxin A. She recovered completely after eight months. A switch between different formulations of botulinum toxin type A should prompt caution when carrying out unit conversions. Distant side effects may appear, including paresis in the contralateral limbs.


2021 ◽  
pp. 1-4
Author(s):  
Leandra Reguero del Cura ◽  
Marta Drake Monfort ◽  
Adrian De Quintana Sancho ◽  
Marcos Antonio González López

Perianal hyperhidrosis (HH) is a rare form of primary focal HH and may become a major problem for the patient with a significant psychosocial burden and negative impact on the quality of life. Botulinum toxin injections are widely used as a second-line treatment option for axillary, palmar, and plantar HH with a good safety profile. Herein, we pre­sent a case of primary perianal HH successfully treated with Botulinum toxin A at a dose higher than that previously reported in literature, with a longer response, a higher degree of satisfaction, and no adverse effects. Moreover, we review the main aspects of the perianal anatomy that are essential to carry out the technique correctly and make dermatologists achieve expertise with the procedure.


PM&R ◽  
2017 ◽  
Vol 9 ◽  
pp. S155-S156
Author(s):  
Lynne Turner-Stokes ◽  
Stephen Ashford ◽  
Jorge Jacinto ◽  
Klemens Fheodoroff ◽  
Pascal Maisonobe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document